These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 37398137)
21. Differential effects of opioid agonists on G protein expression in CHO cells expressing cloned human opioid receptors. Xu H; Wang X; Partilla JS; Bishop-Mathis K; Benaderet TS; Dersch CM; Simpson DS; Prisinzano TE; Rothman RB Brain Res Bull; 2008 Sep; 77(1):49-54. PubMed ID: 18639745 [TBL] [Abstract][Full Text] [Related]
22. Residency time of agonists does not affect the stability of GPCR-arrestin complexes. Mösslein N; Pohle LG; Fuss A; Bünemann M; Krasel C Br J Pharmacol; 2022 Aug; 179(16):4107-4116. PubMed ID: 35352338 [TBL] [Abstract][Full Text] [Related]
23. The high efficacy of muscarinic M4 receptor in D1 medium spiny neurons reverses striatal hyperdopaminergia. Nair AG; Castro LRV; El Khoury M; Gorgievski V; Giros B; Tzavara ET; Hellgren-Kotaleski J; Vincent P Neuropharmacology; 2019 Mar; 146():74-83. PubMed ID: 30468798 [TBL] [Abstract][Full Text] [Related]
24. Adrenergic Agonists Bind to Adrenergic-Receptor-Like Regions of the Mu Opioid Receptor, Enhancing Morphine and Methionine-Enkephalin Binding: A New Approach to "Biased Opioids"? Root-Bernstein R; Turke M; Subhramanyam UKT; Churchill B; Labahn J Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29342106 [TBL] [Abstract][Full Text] [Related]
26. Agonist induced homologous desensitization of mu-opioid receptors mediated by G protein-coupled receptor kinases is dependent on agonist efficacy. Kovoor A; Celver JP; Wu A; Chavkin C Mol Pharmacol; 1998 Oct; 54(4):704-11. PubMed ID: 9765514 [TBL] [Abstract][Full Text] [Related]
27. The endogenous kappa agonist, dynorphin(1-13), does not alter basal or morphine-stimulated dopamine metabolism in the nigrostriatal pathway of the rat. Wood PL; Kim HS; Cosi C; Iyengar S Neuropharmacology; 1987 Nov; 26(11):1585-8. PubMed ID: 2893309 [TBL] [Abstract][Full Text] [Related]
28. FRET-based sensors for the human M1-, M3-, and M5-acetylcholine receptors. Ziegler N; Bätz J; Zabel U; Lohse MJ; Hoffmann C Bioorg Med Chem; 2011 Feb; 19(3):1048-54. PubMed ID: 20716489 [TBL] [Abstract][Full Text] [Related]
29. Detection of G protein-selective G protein-coupled receptor (GPCR) conformations in live cells. Malik RU; Ritt M; DeVree BT; Neubig RR; Sunahara RK; Sivaramakrishnan S J Biol Chem; 2013 Jun; 288(24):17167-78. PubMed ID: 23629648 [TBL] [Abstract][Full Text] [Related]
30. Beta 1-adrenergic and dopamine (D1)-receptors coupled to adenylyl cyclase activation in GT1 gonadotropin-releasing hormone neurosecretory cells. Findell PR; Wong KH; Jackman JK; Daniels DV Endocrinology; 1993 Feb; 132(2):682-8. PubMed ID: 8093877 [TBL] [Abstract][Full Text] [Related]
31. Naloxone activation of mu-opioid receptors mutated at a histidine residue lining the opioid binding cavity. Spivak CE; Beglan CL; Seidleck BK; Hirshbein LD; Blaschak CJ; Uhl GR; Surratt CK Mol Pharmacol; 1997 Dec; 52(6):983-92. PubMed ID: 9415708 [TBL] [Abstract][Full Text] [Related]
32. Suppression of the morphine-induced rewarding effect and G-protein activation in the lower midbrain following nerve injury in the mouse: involvement of G-protein-coupled receptor kinase 2. Ozaki S; Narita M; Narita M; Iino M; Miyoshi K; Suzuki T Neuroscience; 2003; 116(1):89-97. PubMed ID: 12535942 [TBL] [Abstract][Full Text] [Related]
33. No evidence for presynaptic opioid receptors on cholinergic, but presence of kappa-receptors on dopaminergic neurons in the rabbit caudate nucleus: involvement of endogenous opioids. Jackisch R; Hotz H; Hertting G Naunyn Schmiedebergs Arch Pharmacol; 1993 Sep; 348(3):234-41. PubMed ID: 8232601 [TBL] [Abstract][Full Text] [Related]
34. Functional interaction between alpha2-adrenoceptors, mu- and kappa-opioid receptors in the guinea pig myenteric plexus: effect of chronic desipramine treatment. Canciani L; Giaroni C; Zanetti E; Giuliani D; Pisani R; Moro E; Trinchera M; Crema F; Lecchini S; Frigo G Eur J Pharmacol; 2006 Dec; 553(1-3):269-79. PubMed ID: 17055479 [TBL] [Abstract][Full Text] [Related]
35. A G protein-coupled receptor (GPCR) in red: live cell imaging of the kappa opioid receptor-tdTomato fusion protein (KOPR-tdT) in neuronal cells. Huang P; Chiu YT; Chen C; Wang Y; Liu-Chen LY J Pharmacol Toxicol Methods; 2013; 68(3):340-5. PubMed ID: 23856011 [TBL] [Abstract][Full Text] [Related]
36. Differential effects of micro-opioid, delta-opioid and kappa-opioid receptor agonists on dopamine receptor agonist-induced climbing behavior in mice. Ito S; Mori T; Sawaguchi T Behav Pharmacol; 2006 Dec; 17(8):691-701. PubMed ID: 17110795 [TBL] [Abstract][Full Text] [Related]
37. Clathrin and GRK2/3 inhibitors block δ-opioid receptor internalization in myenteric neurons and inhibit neuromuscular transmission in the mouse colon. DiCello JJ; Rajasekhar P; Eriksson EM; Saito A; Gondin AB; Veldhuis NA; Canals M; Carbone SE; Poole DP Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G79-G89. PubMed ID: 31091149 [TBL] [Abstract][Full Text] [Related]
38. Quinpirole attenuates striatal c-fos induction by 5-HT, opioid and muscarinic receptor agonists. Cook DF; Wirtshafter D Eur J Pharmacol; 1998 May; 349(1):41-7. PubMed ID: 9669494 [TBL] [Abstract][Full Text] [Related]
39. Allosteric coupling from G protein to the agonist-binding pocket in GPCRs. DeVree BT; Mahoney JP; Vélez-Ruiz GA; Rasmussen SG; Kuszak AJ; Edwald E; Fung JJ; Manglik A; Masureel M; Du Y; Matt RA; Pardon E; Steyaert J; Kobilka BK; Sunahara RK Nature; 2016 Jul; 535(7610):182-6. PubMed ID: 27362234 [TBL] [Abstract][Full Text] [Related]
40. Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes. Katritch V; Reynolds KA; Cherezov V; Hanson MA; Roth CB; Yeager M; Abagyan R J Mol Recognit; 2009; 22(4):307-18. PubMed ID: 19353579 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]